Learn how you can manage and alleviate your current side effects while actively working to prevent a relapse or secondary cancer using evidence-based, non-toxic therapies.
Click the orange button to the right to learn more.
Our results provide firm evidence for the efficacy of the applied regimen, with close to 80% of pediatric liver cancer patients achieving complete remission at the end of treatment. The study linked
Continue reading“These results suggested that antineoplaston A10 may inhibit the growth of human hepatoma cells through the induction of apoptosis” Conventional oncology may have little to offer the liver
Continue reading